UNSPSC 51283302: Eperezolid

This classification denotes an antibiotic with the molecular formula C18H23FN4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C460ZSU1OW, chemically known as acetamide, n-((3-(3-fluoro-4-(4-(hydroxyacetyl)-1-piperazynyl)phenyl)- 2-oxo-5-oxazolidinyl)methyl)-, (s)- but generally known as eperezolid, which bears US NIH Compound Identifier 73214. European Medicines Agency schedules Eperezolid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06559MIG.

UNSPSC 51283302 Eperezolid is a Commodity code that nominally covers a specific antibiotic product, but recent state and local procurement activity under this code shows little relevance to eperezolid itself. The two most recent opportunities tagged to this code involve pharmaceutical procurement through cooperative purchasing and direct purchase of naloxone and drug deactivation systems — neither involving eperezolid. State and local procurement offices appear to use this code inconsistently or as a catch-all for pharmaceutical supply categories that do not align cleanly with the product name. Buyers using this code span state health departments and county government agencies, though the sample is too limited to characterize a dominant issuing-body pattern.

The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026 for doxycycline and ciprofloxacin through the MMCAP Infuse cooperative purchasing consortium, with a total award of $2,999,999.11 over three years. Seminole County, Florida released an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida. Recent activity appears limited to Florida and Illinois, though the code's inconsistent application to actual eperezolid procurement makes this code a low-confidence signal for targeted business development.